Clinical Trial 41938

Chicago, IL 60617


This study is a Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of Olorinab in Subjects with Irritable Bowel Syndrome Experiencing Abdominal Pain

Qualified Participants Must:

• Be male or female
• 18 to 70 years old
• Clinical diagnosis of Irritable Bowel Syndrome

Qualified Participants May Receive:

  • Compensation for participation and travel
  • Free consultation at our Hyde Park office
  • Travel provided from our Hyde Park office to our Stony Island office

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.